Skip to content
Ina HF Carmet
Indonesian Heart Failure and Cardiometabolic Disease Working Group
Home
About
About InaHF
Committee
Members
News
Events
Event
Past Event
Recording
HF Clinic
Libraries & Guidelines
InaHF Position Statements
InaHF National Guidelines
International Guidelines
Member Publication
Programs
InaHF Preceptorship Programs
i-HEFCARD
i-HEFCARD 2024
i-HEFCARD 2024 Day 1
i-HEFCARD 2024 Day 2
i-HEFCARD 2023
i-HEFCARD 2023 Day 1
i-HEFCARD 2023 Day 2
i-TREAT HF
Close
Home
About
About InaHF
Committee
Members
News
Events
Event
Past Event
Recording
HF Clinic
Libraries & Guidelines
InaHF Position Statements
InaHF National Guidelines
International Guidelines
Member Publication
Programs
InaHF Preceptorship Programs
i-HEFCARD
i-HEFCARD 2024
i-HEFCARD 2024 Day 1
i-HEFCARD 2024 Day 2
i-HEFCARD 2023
i-HEFCARD 2023 Day 1
i-HEFCARD 2023 Day 2
InaHF Position Statements
You are here:
Home
InaHF Position Statements
2022; Scientific Statement of SGLT2i
2022; ARNI Restriction in National Coverage (JKN)
2020; Screening Pasien Gagal Jantung pada Pendemi Covid-19
2020; PPK Miokarditis pada Covid-19
Go to Top